Overview
- The stock fell about 31.5% intraday after the fiscal Q2 2025 report.
- Non‑GAAP EPS came in at $0.20, topping forecasts, while GAAP EPS was $0.11, down from $0.13 a year earlier.
- Revenue reached $65.9 million versus the $67.2 million consensus, though sales rose roughly 21% year over year.
- Management guided Q3 sales to $65 million to $70 million and projected GAAP EPS of about $0.05.
- Despite the drop, the company’s market value hovered near $1.8 billion, with valuation metrics flagged as steep and some advisors recommending selling.